Kenmotsu H - Search Results

1

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L).

Wakuda K, Kenmotsu H, Sato Y, Nakamura A, Akamatsu H, Tachihara M, Miura S, Yokoyama T, Mori K, Nakagawa K, Yamamoto N. Wakuda K, et al. Among authors: kenmotsu h. BMC Cancer. 2023 Sep 25;23(1):902. doi: 10.1186/s12885-023-11417-w. BMC Cancer. 2023. PMID: 37749521 Free PMC article.

2

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reports.

Shukuya T, Takahashi T, Kaira R, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Kaira K, Murakami H, Endo M, Takahashi K, Yamamoto N. Shukuya T, et al. Among authors: kenmotsu h. Cancer Sci. 2011 May;102(5):1032-7. doi: 10.1111/j.1349-7006.2011.01887.x. Epub 2011 Feb 28. Cancer Sci. 2011. PMID: 21272159 Free article.

3

Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure.

Shukuya T, Takahashi T, Naito T, Kaira R, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Murakami H, Harada H, Mitsuya K, Endo M, Nakasu Y, Takahashi K, Yamamoto N. Shukuya T, et al. Among authors: kenmotsu h. Lung Cancer. 2011 Dec;74(3):457-61. doi: 10.1016/j.lungcan.2011.04.007. Epub 2011 May 14. Lung Cancer. 2011. PMID: 21571388

4

The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.

Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y, Tsuya A, Kaira K, Murakami H, Takahashi T, Endo M, Yamamoto N. Kenmotsu H, et al. J Thorac Oncol. 2011 Jul;6(7):1242-6. doi: 10.1097/JTO.0b013e318216ee6b. J Thorac Oncol. 2011. PMID: 21623239 Free article.

5

18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.

Kaira K, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Shukuya T, Kenmotsu H, Naito T, Hayashi I, Oriuchi N, Endo M, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: kenmotsu h. Eur J Radiol. 2012 Sep;81(9):2423-9. doi: 10.1016/j.ejrad.2011.09.017. Epub 2011 Nov 4. Eur J Radiol. 2012. PMID: 22055682

6

Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence.

Kaira K, Takahashi T, Murakami H, Shukuya T, Kenmotsu H, Naito T, Oriuchi N, Kanai Y, Endo M, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: kenmotsu h. Anticancer Res. 2011 Nov;31(11):3775-82. Anticancer Res. 2011. PMID: 22110199

7

L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma.

Kaira K, Oriuchi N, Takahashi T, Nakagawa K, Ohde Y, Okumura T, Murakami H, Shukuya T, Kenmotsu H, Naito T, Kanai Y, Endo M, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: kenmotsu h. Anticancer Res. 2011 Dec;31(12):4075-82. Anticancer Res. 2011. PMID: 22199264

8

Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancer.

Inomata M, Shukuya T, Takahashi T, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Murakami H, Harada H, Endo M, Yamamoto N. Inomata M, et al. Among authors: kenmotsu h. Anticancer Res. 2011 Dec;31(12):4519-23. Anticancer Res. 2011. PMID: 22199325

9

Prognostic impact of circulating tumor cells in patients with small cell lung cancer.

Naito T, Tanaka F, Ono A, Yoneda K, Takahashi T, Murakami H, Nakamura Y, Tsuya A, Kenmotsu H, Shukuya T, Kaira K, Koh Y, Endo M, Hasegawa S, Yamamoto N. Naito T, et al. Among authors: kenmotsu h. J Thorac Oncol. 2012 Mar;7(3):512-9. doi: 10.1097/JTO.0b013e31823f125d. J Thorac Oncol. 2012. PMID: 22258473 Free article.

10

Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.

Shukuya T, Takahashi T, Harada H, Akamatsu H, Sakaguchi C, Imai H, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Murakami H, Endo M, Takahashi K, Yamamoto N. Shukuya T, et al. Among authors: kenmotsu h. Anticancer Res. 2012 Feb;32(2):675-80. Anticancer Res. 2012. PMID: 22287762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page